2010China Modern MedicineRequires access

Clinical research on prevention of mifepristone to recurrence of uterine fibroids after myomectomy

Xuemei Pan

Open publisher page 0 citations

Abstract

Objective:To evaluate the mifepristone' s prevention to recurrence of uterine fibroids after myomectomy.Methods:70 cases of uterine fibroids were randomly divided into surgery group and combined treatment group,both groups underwent laparoscopic myomectomy,the patients of the combined treatment group received postoperative treatment with mifepristone.All patients were analysis of recurrence in 12 months,the serum level of estradiol(E2) and progesterone hormone in 3 months and 12 months after surgery.Results:After 3 months,the serum level of estradiol(E2) and progesterone of the combined treatment group were significantly lower than that of the surgery group.After 12 months,there were no signifi cant difference between the two groups.Recurrence rate of the combined treatment group was significantly lower than that of the surgery group.Conclusion:Mifepristone may be effective in preventing the recurrence of uterine fibroids after myomectomy.

About this research paper

What this paper is about

Objective:To evaluate the mifepristone' s prevention to recurrence of uterine fibroids after myomectomy.Methods:70 cases of uterine fibroids were randomly divided into surgery group and combined treatment group,both groups underwent laparoscopic myomectomy,the patients of the combined treatment group received postoperative treatment with mifepristone.All patients were analysis of recurrence in 12 months,the serum level of estradiol(E2) and progesterone hormone in 3 months and 12 months after surgery.Results:After 3 months,the serum level of estradiol(E2) and progesterone of the combined treatment group were significantly lower than that of the surgery group.After 12 months,there were no signifi cant difference between the two groups.Recurrence rate of the combined treatment group was significantly lower than that of the surgery group.Conclusion:Mifepristone may be effective in preventing the recurrence of uterine fibroids after myomectomy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the mifepristone' s prevention to recurrence of uterine fibroids after myomectomy.Methods:70 cases of uterine fibroids were randomly divided into surgery group and combined treatment group,both groups underwent laparoscopic myomectomy,the patients of the combined treatment group received postoperative treatment with mifepristone.All patients were analysis of recurrence in 12 months,the serum level of estradiol(E2) and progesterone hormone in 3 months and 12 months after surgery.Results:After 3 months,the serum level of estradiol(E2) and progesterone of the combined treatment group were significantly lower than that of the surgery group.After 12 months,there were no signifi cant difference between the two groups.Recurrence rate of the combined treatment group was significantly lower than that of the surgery group.Conclusion:Mifepristone may be effective in preventing the recurrence of uterine fibroids after myomectomy.

Key concepts: Medicine, Mifepristone, Uterine fibroids, Clinical efficacy, Surgery, Hormone, Gynecology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical research on prevention of mifepristone to recurrence of uterine fibroids after myomectomy — Research Paper | ScholarLens